Literature DB >> 33103406

Gastroesophageal reflux disease: key messages for clinicians.

Margherita Saracco1, Vincenzo Savarino2, Giorgia Bodini2, Giorgio M Saracco1,3, Rinaldo Pellicano4.   

Abstract

Gastroesophageal reflux disease (GERD) is a chronic common disorder for which patients often refer to specialists. In the last decades, numerous studies helped to clarify the pathophysiology and the natural history of this disease. Currently, in the clinical setting, GERD is defined by the presence of symptoms that, when endoscopic investigation is required, permit to distinguish between cases with or without associated esophageal mucosal injuries. These conditions are called erosive reflux disease and non-erosive reflux disease (NERD), respectively. The latter is the most common manifestation of GERD. Symptoms are defined typical, as heartburn and regurgitation, and atypical (also called extra-esophageal), as coughing and/or wheezing, hoarseness, sore throat, otitis media, and dental manifestations. In this context, it is crucial for clinicians to investigate the presence of features of suspected malignancy, as unexplained weight loss, anemia, dysphagia, persistent vomiting, familiar history of cancer, long history of GERD, and beginning of GERD symptoms after the age of 50 years. The presence of these risk factors should induce to perform an endoscopic examination. Particular attention should be given to functional conditions that can mimic GERD, such as functional heartburn and hypersensitive esophagus as well as, more rarely, eosinophilic esophagitis. The former ones have different pathophysiology and this explains the frequent non-response to proton pump inhibitor drugs. This narrative review provides to clinicians a useful and practical overview of the state-of-the-art on advancements in the knowledge of GERD.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33103406     DOI: 10.23736/S2724-5985.20.02783-X

Source DB:  PubMed          Journal:  Minerva Gastroenterol (Torino)        ISSN: 2724-5985


  3 in total

Review 1.  Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease.

Authors:  Cao Xu; Xiaoping Niu
Journal:  Gastroenterol Res Pract       Date:  2022-01-20       Impact factor: 2.260

2.  Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease.

Authors:  Hye Kyung Jeon; Gwang Ha Kim; Moon Won Lee; Dong Chan Joo; Bong Eun Lee
Journal:  J Clin Med       Date:  2022-04-01       Impact factor: 4.241

3.  Diagnostic value of reflux episodes in gastroesophageal reflux-induced chronic cough: a novel predictive indicator.

Authors:  Shengyuan Wang; Siwan Wen; Xiao Bai; Mengru Zhang; Yiqing Zhu; Mingyan Wu; Lihua Lu; Cuiqin Shi; Li Yu; Xianghuai Xu
Journal:  Ther Adv Chronic Dis       Date:  2022-08-17       Impact factor: 4.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.